Active substance |
Human immunoglobuline |
Holder |
CSL Behring nv/sa |
Status |
Running |
Indication |
Treatment of bleeds in patients with acquired von Willebrand syndrome |
Documents publics |
|
Last update |
07/10/2022 |
Privigen
Last updated on 13/02/2024